Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Looking for maximum cashback on groceries? Check out our top credit card recommendations that offer the best rewards.
24,442 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...
FUTY has delivered 64% returns over five years while charging just 0.084% in fees, as the utility sector blends stead...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
As U.S. markets face volatility, a single low-cost ETF offering broad exposure to Europe and Japan is drawing steady ...
ThredUp's chief argues that a permanent four-day workweek provides a competitive edge in attracting talent. The broad...
U.S. equities extended gains as investors digested a leadership shift at the Federal Reserve and a cautious path for ...
A leading DeFi security expert says AI-powered coding agents have made the space unsafe. The warning comes as attack ...